Rigel Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
05 Feb 24 | SellUS$60,082 | Raul Rodriguez | Individual | 5,289.4 | US$11.40 | |
05 Feb 24 | SellUS$14,338 | Dean Schorno | Individual | 1,262.8 | US$11.40 | |
05 Feb 24 | SellUS$16,496 | David Santos | Individual | 1,451.9 | US$11.40 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 201,804 | 1.15% |
Hedge Funds | 2,667,697 | 15.2% |
General Public | 6,805,994 | 38.7% |
Institutions | 7,919,482 | 45% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,624,000 | US$21.6m | 5.73% | 0.53% | |||
1,512,899 | US$20.2m | 2.23% | no data | |||
1,422,876 | US$19.0m | -1.33% | no data | |||
1,043,697 | US$13.9m | 12.9% | 1.09% | |||
961,629 | US$12.8m | 2.66% | no data | |||
550,138 | US$7.3m | 0.66% | 0.02% | |||
390,782 | US$5.2m | 3.04% | no data | |||
365,243 | US$4.9m | -2.21% | no data | |||
305,000 | US$4.1m | 193% | 1.44% | |||
238,253 | US$3.2m | 4.06% | 0.01% | |||
144,946 | US$1.9m | -28.3% | no data | |||
140,069 | US$1.9m | -3.25% | no data | |||
135,920 | US$1.8m | 0% | 0.01% | |||
131,163 | US$1.7m | 0% | no data | |||
118,878 | US$1.6m | -34.5% | no data | |||
105,860 | US$1.4m | 2,190% | no data | |||
100,000 | US$1.3m | 0% | 0.47% | |||
92,448 | US$1.2m | 37.4% | 0.09% | |||
90,245 | US$1.2m | -34.6% | 0.08% | |||
89,934 | US$1.2m | 0% | 0.02% | |||
80,910 | US$1.1m | 35.2% | no data | |||
77,409 | US$1.0m | 4.1% | no data | |||
75,563 | US$1.0m | 3.15% | no data | |||
64,540 | US$859.7k | 8.4% | 0.01% | |||
59,499 | US$792.5k | 13.6% | no data |